ams-OSRAM's Portfolio Diet: Will the Photonics Core Pay for the Makeover?
Published on 09/11/2026 at 12:30 | Editorial boerse-global.de
The tungsten and molybdenum operation in Schwabmünchen is not the crown jewel of ams-OSRAM. It is, however, the latest piece of evidence that management is serious about slimming the company down to a photonics-focused core — and the market is still deciding whether that is a promise or a warning.
Elmet Group Co. will take over the Bavarian site's tungsten and molybdenum production, with the transaction slated to close in the first quarter of 2027, subject to regulatory clearance and an orderly transition. Several hundred jobs at the location are expected to remain, and Elmet has said it intends to invest there. The deal slots into a string of disposals: the non-optical sensor business went to Infineon on July 1, and in May the company agreed to sell its CMOS image sensor unit to California-based Indie Semiconductor for roughly EUR 40 million.
Each transaction, viewed alone, looks like a peripheral asset being shed. Stacked together, they sketch a management team deliberately carving the portfolio down to Photonics — light and sensor technology in the narrower sense — with an eye on automotive applications and AR glasses. The newly established Digital Photonics Business Lines, formally set up on July 1, are meant to form the backbone of that focused company.
The Numbers Behind the Shrinkage
In the second quarter of 2026, ams-OSRAM generated revenue of EUR 805 million, hitting its own guidance. For the third quarter, the company guided to sales of between EUR 770 million and EUR 870 million, alongside an adjusted EBITDA margin of 16.0 percent, give or take 1.5 percentage points. Full-year 2026 guidance was left untouched, even though divestitures and currency effects are expected to push total revenue somewhat lower.
Management itself calls 2026 a "transition year," with temporary pressure on the adjusted EBITDA margin from one-off effects — a candid framing that acknowledges the rebuild costs money before it pays off. The company has also flagged an adjusted EBITDA margin of 16.9 percent in recent reporting, a figure that offers some comfort to those betting on margin stabilization.
Should investors sell immediately? Or is it worth buying ams-OSRAM?
The real test is not the sale of individual plants but whether the remaining core grows profitably enough to carry the restructuring costs and the debt load. On that front, the order book offers encouragement: roughly EUR 1.6 billion in record design wins in the second quarter alone, and about EUR 2.5 billion across the first half — figures that point to a full pipeline for years to come. In May, ams-OSRAM also signed a development contract with a leading AI-photonics customer and sketched a path to positive free cash flow in 2027.
That path, though, is a wager rather than a guarantee. Free cash flow has remained negative, and the company separately placed a EUR 1 billion bond to reduce its interest burden. It also plans to spend between EUR 120 million and EUR 150 million on a tender offer to buy back portions of its convertible bonds maturing in 2027 and senior notes maturing in 2029 — balance-sheet housekeeping aimed at trimming interest costs and buying room for the overhaul.
What the Market Is Pricing
The stock has been volatile in both directions. One trading day after the Schwabmünchen announcement, the shares fell 4.1 percent — a move that can be read as market unease about yet another shrinking step, even though the site retains hundreds of jobs and the buyer plans to invest. More recently, the shares have recovered, trading at EUR 19.55 after a 4.0 percent daily gain, which puts them about 2.7 percent above the 50-day moving average of EUR 19.03 — a sign the advance is being carried by the short-term trend line rather than being a one-off spike.
Even so, the gap to the 52-week high of EUR 26.70 remains substantial at roughly 27 percent, or 30 percent depending on the measurement point — a reminder that the recovery is far from a full return to old peaks. Over the past twelve months, the stock has gained 77 percent, and it is up 123 percent since the start of the year. An earlier reading put the year-to-date advance at 132 percent. Either way, the market has already priced in a considerable vote of confidence in the turnaround.
The bull case rests on a smooth handover to Elmet, proceeds used for deleveraging as planned, and a leaner portfolio centered on sensors and optical semiconductors stabilizing margins. If the design-win backlog converts into revenue growth in coming quarters, the stock — after its run — could still have room toward its prior annual high. The extension of CEO Aldo Kamper's mandate through 2031, which rules out a leadership change in the coming years, would likely be read by investors as a continuity signal, provided the restructuring succeeds.
The bear case is the combination of high leverage and persistently negative cash flow. If free cash flow stays underwater for several quarters, the recent bond issuance may not be the last refinancing step. The Elmet deal is not yet complete, and regulatory clearance plus the technical transition into the first quarter of 2027 carry delay risk. An annualized volatility of 60 percent shows the market still prices the stock as a wide-swinging bet, not a stable name with a secured turnaround.
Where the Story Goes Next
On the product side, the direction is visible. At the Automechanika trade fair in Frankfurt, which runs through Saturday, ams-OSRAM is presenting solutions for the automotive aftermarket. In microLED arrays for AR smart glasses, the company reported milestones reached in the second quarter.
Whether a leaner, more profitable company emerges from all this will not be decided by individual divestiture headlines. It will hinge on whether the promised positive free cash flow in 2027 becomes reality. The next concrete checkpoint is the closing of the Schwabmünchen transaction itself — only then will it be clear whether the portfolio overhaul delivers the financial relief the market is currently counting on. If the design wins keep converting into revenue and the Elmet deal stays on schedule, the recovery path should hold. If free cash flow fails to turn positive, or the sale slips past the first quarter of 2027, the market will reprice the recovery.
Ad
ams-OSRAM Stock: New Analysis - 11 September
Fresh ams-OSRAM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
